Methyldopa hydrochloride (L-(-)-α-Methyldopa hydrochloride) is used as an α-adrenergic agonist selective for α2-adrenergic receptors; it acts as a prodrug metabolized in the central nervous system to α-methylnorepinephrine; it has been shown to decrease the hyperglycemic response and reduce plasma glucose concentration by 24% in dieldrin-exposed rats following intraperitoneal administration.